Drawing on our executive search practice, we put this together to give employers a grounded, practical view they can act on. Leading a contract development and manufacturing organisation requires something distinct from leading internal pharmaceutical manufacturing: you are running a service business where clients are demanding, quality failures damage relationships as well as compliance standing, and capacity utilisation drives profitability. The best CDMO leaders combine manufacturing rigour with genuine commercial and client-management capability, and executives from captive manufacturing frequently lack the second half.
Key Takeaways
- A CDMO is a service business, not just a manufacturing operation.
- Client relationship management is a core leadership responsibility.
- Capacity utilisation and mix drive profitability directly.
- Quality failures carry commercial as well as regulatory consequences.
- Captive manufacturing leaders often lack the commercial dimension.
A Service Business With Manufacturing Inside It
Internal pharmaceutical manufacturing serves one client with aligned incentives. A CDMO serves many, each with their own timelines, quality expectations, technical demands, and commercial leverage, and it competes for their business. This makes client management, contract structuring, technology transfer execution, and responsiveness central leadership concerns alongside operational performance. Leaders who understand manufacturing deeply but have never carried commercial responsibility for client relationships frequently underestimate how much of the job is external, and they struggle when a major client escalates.
Utilisation and Mix Drive the Economics
CDMO profitability depends heavily on capacity utilisation and the mix of work: high-value, technically demanding programmes against volume work, long-term commitments against spot capacity, and the balance between development services and commercial supply. Leaders must make judgments about which business to pursue, what to price, when to invest in capacity ahead of demand, and how to manage the risk of client concentration. This is a commercial and capital allocation skill set that captive manufacturing leadership does not develop, and it should be assessed explicitly rather than assumed.
Technology Transfer as a Core Competence
Much of a CDMO’s reputation rests on executing technology transfers reliably, taking a client’s process and making it work at the CDMO’s site, on schedule and to specification. This is technically demanding and relationship-intensive, and failures are highly visible to clients who have alternatives. Leaders must build organisations that transfer well repeatedly, which requires disciplined processes, strong technical staff, and realistic commitment-setting during business development. Assess candidates on how they have handled transfers that went badly, since these reveal more than the successful ones.
Quality Failures Cut Twice
In a CDMO, a quality problem carries both regulatory consequences and commercial ones: an inspection finding affects standing with authorities, and it simultaneously damages confidence among clients whose own products and regulatory positions depend on the site. Clients audit CDMOs regularly and move business over quality concerns. This means CDMO quality leadership must satisfy two demanding audiences, and leaders must understand that quality is a commercial asset rather than only a compliance obligation. Candidates who articulate this dual character understand the business.
What This Looks Like in Practice
A CDMO hiring senior leadership assesses commercial and client-management capability alongside manufacturing rigour, probes judgment about capacity investment, pricing, and client concentration, examines how the candidate handled failed technology transfers, and looks for genuine understanding that quality serves both regulators and clients.
The Mistake Employers Keep Making
The most common mistake is recruiting an accomplished captive manufacturing leader on the strength of their operational record, assuming a CDMO is the same work with external customers. The executive runs the plants well and struggles with client escalations, commercial negotiations, capacity investment decisions, and the relationship consequences of missed commitments. Manufacturing excellence is mistaken for CDMO leadership.
Captive Manufacturing vs CDMO Leadership
| Dimension | Captive | CDMO |
|---|---|---|
| Clients | One, internally aligned | Many, with alternatives |
| Commercial responsibility | Limited | Central |
| Economics | Cost centre | Utilisation and mix driven |
| Technology transfer | Occasional | Core repeated competence |
| Quality consequence | Regulatory | Regulatory and commercial |
The Bottom Line
CDMO leadership is a service business role built on a manufacturing foundation, requiring client management, capacity and mix judgment, reliable technology transfer, and quality treated as a commercial asset, so assess the commercial dimension explicitly rather than assuming strong captive manufacturing experience transfers. Matching the person to the real demands of the role, not just a strong generalist to a title, is what separates success from expensive disappointment.
Related Reading
For more, see Hiring Trends in Pharmaceutical Manufacturing Leadership, Recruiting Leadership for Generic Drug Manufacturers, What Sets Top Pharma Executive Recruiters Apart.
Frequently Asked Questions
- Q: How does CDMO leadership differ from internal manufacturing?
- A: A CDMO is a service business serving many clients with alternatives, so client management, commercial negotiation, and capacity economics sit alongside operational performance.
- Q: What drives CDMO profitability?
- A: Capacity utilisation and business mix, the balance of high-value technical work against volume, long-term commitments against spot capacity, and development services against commercial supply.
- Q: Why is technology transfer so important?
- A: Because much of a CDMO’s reputation rests on transferring client processes reliably and on schedule, and failures are highly visible to clients who can move business.
- Q: How do quality failures differ at a CDMO?
- A: They carry commercial consequences alongside regulatory ones, since clients audit regularly and move business when confidence in a site’s quality erodes.
- Q: Can captive manufacturing leaders run a CDMO?
- A: Some can, but the commercial, client-management, and capacity-investment dimensions are genuinely different and should be assessed explicitly rather than assumed to transfer.
![](https://www.jrgpartners.com/wp-content/uploads/2025/12/tanya-gallardo.jpeg")
Tanya Gallardo
Managing Director, Executive Search & AI Talent Strategy
Tanya Gallardo is the Managing Director of Executive Search & AI Talent Strategy at JRG Partners, leading C-suite and Board engagements across key growth sectors including Technology, Financial Services, and Manufacturing.
With over 18 years of experience specializing in disruptive technology leadership, Tanya is recognized as a leading authority on talent architecture for future-focused executive roles, such as the Chief AI Officer (CAIO) and Chief Digital Officer (CDO). Her expertise lies in accurately assessing the cultural fit and technical depth required to ensure a high return on investment (ROI) for critical leadership appointments.
Prior to her role at JRG Partners, Tanya held senior roles directing global talent acquisition strategies at a major publicly-traded technology firm, advising on organizational design and succession planning for emerging executive functions. She is a recognized speaker and contributor to industry events, sharing data-driven insights on executive compensation, leadership development, and the measurable business impact of C-suite talent.
